Scheetz Seth, Pandey Deepali, Pesavento Todd E, Singh Priyamvada
Internal Medicine, The Ohio State University College of Medicine, Columbus, USA.
Internal Medicine, Saint Vincent Hospital, Worcester, USA.
Cureus. 2020 Jan 21;12(1):e6719. doi: 10.7759/cureus.6719.
Renal transplant patients on immunosuppression are at risk for malignancy. One form of malignancy that commonly affects this population is Kaposi-sarcoma. Kaposi-sarcoma is a human herpesvirus-8 (HHV-8)-driven process classically associated with skin lesions in immunocompromised patients. The pulmonary system may be involved in disseminated disease. In this case, a renal transplant patient was re-admitted with acute hypoxic respiratory failure and hemoptysis of an unclear etiology. Following a broad workup, HHV-8 PCR and a lymph node biopsy confirmed pulmonary Kaposi-sarcoma. Workup for multicentric Castleman disease was negative. The patient was treated with liposomal doxorubicin, ganciclovir, and prednisone. Her immunosuppression was changed to sirolimus and she is scheduled to complete six cycles of liposomal doxorubicin.
接受免疫抑制治疗的肾移植患者有患恶性肿瘤的风险。一种通常影响这一人群的恶性肿瘤形式是卡波西肉瘤。卡波西肉瘤是一种由人类疱疹病毒8型(HHV-8)驱动的疾病,典型地与免疫功能低下患者的皮肤病变相关。肺部系统可能参与播散性疾病。在本病例中,一名肾移植患者因病因不明的急性缺氧性呼吸衰竭和咯血再次入院。经过全面检查,HHV-8聚合酶链反应(PCR)和淋巴结活检确诊为肺卡波西肉瘤。多中心Castleman病的检查结果为阴性。该患者接受了脂质体阿霉素、更昔洛韦和泼尼松治疗。她的免疫抑制治疗改为西罗莫司,并且她计划完成六个周期的脂质体阿霉素治疗。